Real-time monitoring of superoxide generation and cytotoxicity in neuroblastoma mitochondria induced by 1-trichloromethyl- 1,2,3,4-tetrahydro-beta-carboline

Redox Report

Volumn 17, Issue 3, 2012, Pages 108-114

  Boulton, Sarah Jayne ^a   Keane, Paul C ^a   Morris, Christopher M ^a   McNeil, Calum J ^a   Manning, Philip ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Amperometric monitoring; Complex I; Mitochondria; Oxidative stress; Parkinson's disease; TaClo

Indexed keywords

1 TRICHLOROMETHYL 1,2,3,4 TETRAHYDRO BETA CARBOLINE; ANTIMYCIN A1; CARBOLINE DERIVATIVE; CHORAL HYDRATE; NEUROTOXIN; ROTENONE; SUPEROXIDE; UNCLASSIFIED DRUG;

AMPEROMETRY; ARTICLE; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; MITOCHONDRION; NERVE CELL NECROSIS; NEUROBLASTOMA; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIMYCIN A; ANTINEOPLASTIC AGENTS; CARBOLINES; CELL LINE, TUMOR; CELL RESPIRATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTRON TRANSPORT COMPLEX I; HUMANS; MITOCHONDRIA; NEUROBLASTOMA; OXAZINES; ROTENONE; SUPEROXIDES; TIME FACTORS; XANTHENES;

PARKINSONIA;

EID: 84863793241     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000212Y.0000000011     Document Type: Article

References (37)

1. Langston JW, Ballard P. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci 1984;11(Suppl. 1):160-5.
2. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 1989;26:507-14.
3. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidineanalog synthesis. Science 1983;219:979-80.
4. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 1985;82:2173-7.
5. Cleeter MWJ, Cooper JM, Schapira AHV. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem 1992;58: 786-9.
6. Hartley A, Stone JM, Heron C, Cooper JM, Schapira AHV. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease. J Neurochem 1994;63: 1987-90.
7. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40: 663-71.
8. Janetzky B, Gille G, Abdel-mohsen M, God R, Rausch W-D, Bringmann G, et al. Effect of highly halogenated β-carbolines on dopaminergic cells in culture and on mitochondrial respiration. Drug Develop Res 1999;46:51-6.
9. Bringmann G, God R, Feineis D, Janetzky B, Reichmann H. TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain. J Neural Transm-Supp 1995;46:245-54.
10. Kochen W, Kohlmuller D, De Biasi P, Ramsay R, Kochen W, Kohlmuller D, et al. The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Adv Exp Med Biol 2003;527:253-63.
11. Akundi RS, Macho A, Munoz E, Lieb K, Bringmann G, Clement HW, et al. 1-Trichloromethyl-1,2,3,4-tetrahydro-betacarboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH. J Neurochem 2004;91:263-73.
12. Majander A, Finel M, Wikström M. Diphenyleneiodonium inhibits reduction of iron-sulfur clusters in the mitochondrial NADH-ubiquinone oxidoreductase (complex I). J Biol Chem 1994;269:21037-42.
13. Henderson JR, Swalwell H, Boulton SJ, Manning P, Birch-Machin M, McNeil CJ. Direct, real-time monitoring of superoxide generation in isolated mitochondria. Free Radic Res 2009;43: 1-7.
14. Storch A, Hwang YI, Bringmann G, Feineis D, Ott S, Brückner R, et al. Cytotoxicity of chloral-derived β-carbolines is not specific towards neuronal nor dopaminergic cells. J Neural Trans 2006;113:1895-901.
15. O'Brien J, Wilson I, Orton T, Pognan F. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000;267:5421-6.
16. Tammeveski K, Tenno TT, Mashirin AA, Hillhouse EW, Manning P, McNeil CJ. Superoxide electrode based on covalently immobilized cytochrome c: modelling studies. Free Radic Biol Med 1998;25:973-8.
17. Chang SC, Pereira-Rodrigues N, Henderson JR, Cole A, Bedioui F, McNeil CJ. An electrochemical sensor array system for the direct, simultaneous in vitro monitoring of nitric oxide and superoxide production by cultured cells. Biosens Bioelectron 2005;21:917-22.
18. Manning P, Cookson MR, McNeil CJ, Figlewicz D, Shaw PJ. Superoxide-induced nitric oxide release from cultured glial cells. Brain Res 2001;911:203-10.
19. Manning P, McNeil CJ, Cooper JM, Hillhouse EW. Direct, realtime sensing of free radical production by activated human glioblastoma cells. Free Radic Biol Med 1998;24:1304-9.
20. Liu M, Choi D-Y, Hunter RL, Pandya JD, Cass WA, Sullivan PG, et al. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J Neurochem 2010;112:773-83.
21. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: subtantia nigra regional selectivity. Brain 1991;114:2283-301.
22. Bringmann G, Bruckner R, Mossner R, Feineis D, Heils A, Lesch KP. Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-betacarboline (TaClo) on human serotonergic cells. Neurochem Res 2000;25:837-43.
23. Gonzalez RJ, Tarloff JB. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol In Vitro 2001;15:257-9.
24. Fields RD, Lancaster MV. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab 1993; 11:48-50.
25. Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, et al. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 2004;37:755-67.
26. St-Pierre J, Buckingham JA, Roebuck SJ, Brand MD. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem 2002; 277:44784-90.
27. Lambert AJ, Brand MD. Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). J Biol Chem 2004;297:39414-20.
28. Bringmann G, Feineis D, God R, Fähr S, Wesemann W, Clement HW, et al. Neurotoxic effects on the dopaminergic system induced by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline), a potential mammalian alkaloid: in vivo and in vitro studies. Biogenic Amines 1996;12:83-102.
29. Riederer F, Luborzewski A, God R, Bringmann G, Scholz J, Feineis D, et al. Modification of tyrosine hydroxylase activity by chloral derived β-carbolines in vitro. J Neurochem 2002;81: 814-9.
30. Costa VM, Carvalho F, Bastos ML, Carvalho RA, Carvalho M, Remiao F. Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases. Curr Med Chem 2011;18(15):2272-314.
31. Mladenka P, Hrdina R, Bobrovová Z, Semecky Vr, Vávrová J, Holeková M, et al. Cardiac biomarkers in a model of acute catecholamine cardiotoxicity. Hum Exp Toxicol 2009;28:631-40.
32. Costa VM, Silva R, Tavares LC, Vitorino R, Amado F, Carvalho F, et al. Adrenaline and reactive oxygen species elicit proteome and energetic metabolism modifications in freshly isolated rat cardiomyocytes. Toxicol 2009;260:84-96.
33. 2elevation, not ATP depletion. J Neurosci 2005;25:10029-40.
34. 2upon chronic rotenone treatment. Free Radic Biol Med 2005;39: 133-42.
35. Gerlach M, Xiao AY, Heim C, Lan J, God R, Feineis D, et al. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats. Neurosci Lett 1998;257:17-20.
36. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford: Oxford University Press; 2007.
37. Foley P, Riederer P. Influence of neurotoxins and oxidative stress on the onset and progression of Parkinson's disease. J Neurol 2000;247(Suppl. 2):II82-94.